AdaptHealth (AHCO) Form 4: Board Member Receives 21k-Share Grant

Rhea-AI Filing Summary

Form 4 filing for AdaptHealth Corp. (AHCO) reports that director David S. Williams III acquired 21,346 shares of common stock on 06/26/2025 at a stated price of $0.00 per share, suggesting the shares were received through an equity award or similar non-cash grant. Following the transaction, Williams now beneficially owns 58,245 shares, all held directly. No derivative securities or dispositions were disclosed, and the filing was signed on 06/30/2025 by an attorney-in-fact.

• Reporting person status: Director, single filer
• Transaction code: “A” (acquisition)
• Ownership form: Direct
• No sales, derivative activity, or 10b5-1 plan indicated

Positive

• Director acquired 21,346 new shares, raising direct holdings to 58,245 shares.

Negative

• None.

Insights

Securities Analyst

TL;DR – Director received 21k new shares; small, informational impact.

The acquisition increases insider holdings but involves no cash outlay, implying an equity award rather than an open-market buy. Because the stake rises to just 58k shares, the absolute ownership remains immaterial relative to AdaptHealth’s total float. The filing does not signal operational or financial changes, so market impact is expected to be limited.

Corporate Governance Specialist

TL;DR – Routine equity grant, governance compliance maintained.

The Form 4 meets Section 16 reporting requirements within two business days. No 10b5-1 notation or group filing appears, and the power-of-attorney signature is properly disclosed. From a governance viewpoint, this is standard board compensation disclosure with no red flags.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams David Solomon III

(Last) (First) (Middle)

6272 CONDON AVE

(Street)

LOS ANGELES CA 90056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2025		A		21,346	A	$0	58,245	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Richard Rew, as attorney-in-fact for David S. Williams III	06/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AdaptHealth (AHCO) shares did the director acquire?

The Form 4 states that David S. Williams III acquired 21,346 common shares.

What is the director’s total ownership after the transaction?

Following the award, the director beneficially owns 58,245 shares of AHCO.

Was cash paid for the shares?

No. The transaction price is reported as $0.00, indicating a non-cash equity grant.

Did the filing disclose any derivative security activity?

No derivative securities were acquired or disposed of in this filing.

Is this Form 4 tied to a 10b5-1 trading plan?

The form does not indicate that the transaction was made under a Rule 10b5-1 plan.